Kendel Orr

Kendel Orr

Vice President | Cell & Gene Therapy Launch I Commercial Strategy I Dynamic Leader | Authentic and Trusted Business Partner | Visionary | Cross-Functional Collaborator | Growth Driver | Team and Culture Builder

Role
Vice President, Head of Sales - U s at Neurotech Pharmaceuticals, Inc.
Location
Kansas City, MO, US
LinkedIn followers
500 followers

About Kendel Orr

With over 20 years of leadership experience in the medical, biotech, and pharmaceutical sectors, I am a sales leader who can build, motivate, and lead high-performing teams across multiple states and regions. I have a Master of Science degree in Physical Therapy from Washington University School of Medicine in St. Louis, and a Bachelor of Science degree in Biology from Missouri State University, as well as multiple certifications from LinkedIn on leadership, sales forecasting, recruiting/hiring, empowering teams, and setting business unit goals.Currently, I am the Head of Sales at Neurotech Pharmaceuticals, a biotech company focused on developing cell based gene therapies for ophthalmic and rare diseases. I have therapeutic experiences in ophthalmology, orthopedics, cardiovascular, urology, nephrology, and endocrinology disciplines, and I have successfully launched and commercialized products, divisions, and companies across multiple therapeutic areas. My core competencies include sales forecasting, active listening, and high performance, as well as a personality profile of Disc=Di, TypeCoach=ENTP, and StrengthFinders: Arranger, Strategic, Woo, Maximizer, and Significance. My mission is to empower my team to drive business and deliver value to our external customers.

Experience

  1. Vice President, Head of Sales - U s

    Neurotech Pharmaceuticals, Inc.

    Oct 2024 — Present

    Neurotech is a private clinical stage biotech company focused on developing transformative therapies for chronic eye disease.The core platform technology, Encapsulated Cell Therapy (ECT) enables continuous production of therapeutic proteins to the eye with current therapeutic area of focus being Macular Telangiectasia (MacTel).\"MacTel\" is a retina orphan disease that leads to gradual loss of central vision. Encelto was approved in March 2025.

Education

  • Washington University School of Medicine in St. Louis

    Master of Science - MS

  • Missouri State University

    Bachelor of Science - BS

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Kendel Orr — Email, Phone Number & Contact Info | Unifers